|
Volumn 14, Issue 2, 2007, Pages 95-97
|
Crystal structure of CETP: New hopes for raising HDL to decrease risk of cardiovascular disease?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ATORVASTATIN;
CHOLESTEROL ESTER TRANSFER PROTEIN;
HIGH DENSITY LIPOPROTEIN;
HIGH DENSITY LIPOPROTEIN CHOLESTEROL;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
LIPID TRANSFER PROTEIN;
LIPOPROTEIN;
TORCETRAPIB;
BLOOD PRESSURE;
CARDIOVASCULAR DISEASE;
CLINICAL TRIAL;
CRYSTAL STRUCTURE;
DRUG BINDING;
DRUG DESIGN;
DRUG MECHANISM;
ELECTRICITY;
HUMAN;
LIPOLYSIS;
LIPOPROTEIN BLOOD LEVEL;
MEDICAL RESEARCH;
MOLECULAR MECHANICS;
PRIORITY JOURNAL;
RISK FACTOR;
SHORT SURVEY;
SIDE EFFECT;
CARDIOVASCULAR DISEASES;
CHOLESTEROL ESTER TRANSFER PROTEINS;
CHOLESTEROL, HDL;
CRYSTALLOGRAPHY, X-RAY;
HUMANS;
LIGANDS;
LIPIDS;
PROTEIN CONFORMATION;
RISK;
|
EID: 33846973994
PISSN: 15459993
EISSN: 15459985
Source Type: Journal
DOI: 10.1038/nsmb0207-95 Document Type: Short Survey |
Times cited : (13)
|
References (22)
|